Back to results
CompletedPhase 4

5-hydroxytryptophan and Creatine for Treatment Resistant Depression Associated With Hypoxia in Females

NCT02356107

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

University of Utah/The Brain Institute

Salt Lake City, Utah, United States

View on ClinicalTrials.gov
5-hydroxytryptophan and Creatine for Treatment Resistant Depression Associated With Hypoxia in Females — TrialFind